Abstract
Insight into the organization of the basal ganglia in the normal, parkinsonian and L-dopa-induced dyskinesia states is critical for the development of newer and more effective therapies for Parkinson's disease. We believe that the basal ganglia can no longer be thought of as a unidirectional linear system that transfers information based solely on a firing-rate code. Rather, we propose that the basal ganglia is a highly organized network, with operational characteristics that simulate a non-linear dynamic system.
MeSH terms
-
Animals
-
Antiparkinson Agents / administration & dosage
-
Antiparkinson Agents / adverse effects*
-
Basal Ganglia / pathology
-
Basal Ganglia / physiopathology*
-
Disease Models, Animal
-
Dyskinesia, Drug-Induced / metabolism
-
Dyskinesia, Drug-Induced / physiopathology*
-
Dyskinesia, Drug-Induced / prevention & control
-
Humans
-
Levodopa / administration & dosage
-
Levodopa / adverse effects*
-
Models, Neurological
-
Neural Pathways
-
Neurons / metabolism
-
Parkinson Disease / metabolism
-
Parkinson Disease / physiopathology*
-
Pulse Therapy, Drug / adverse effects*
-
Receptors, Dopamine / metabolism
Substances
-
Antiparkinson Agents
-
Receptors, Dopamine
-
Levodopa